Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People’s Republic of China

Infectious Diseases of Poverty

Ling-Hua Tang³  Shui-Sen Zhou³  Jun-Hu Chen³  Fang Huang³  Ahmed Adebowale Adedeji¹  Ernest Tambo² 

[1] Department of Pharmacology and Toxicology, Kampala International University Western Campus, P.O.Box 71, Ishaka, Bushenyi, Uganda;School of Medicine & Pharmacy, Houdegbe North American University PK10, Route de Porto-Novo, 06 BP 2080, Cotonou, République du Bénin;National Institute of Parasitic Disease, Chinese Center for Disease Control and Prevention, WHO Collaborating Centre on Malaria, Schisostomiasis and Filariasis, Key Laboratory of Parasite and Vector Biology, Ministry of Health, 207 Rui Jin Er Rd, Shanghai, 200025, People’s Republic of China

关键词: People’s Republic of China;    Sub-Sahara Africa;    health system;    interventions;    scaling up;    funding;    malaria;   

Others  :  805732
DOI  :  10.1186/2049-9957-1-7

 received in 2012-08-28, accepted in 2012-10-12,  发布年份 2012

【 摘 要 】

This review aims at providing synthetic information with scientific evidence on the trends in the malaria events from 1960 to 2011, with the hope that it will help policy makers to take informed decisions on public health issues and intervention designs on malaria control towards elimination in both Sub-Sahara Africa and in the People’s Republic of China by highlighting the achievements, progress and challenges in research on moving malaria from epidemic status towards elimination. Our findings showed that since 1960, malaria control programmes in most countries have been disjointed and not harmonized. Interestingly, during the last decade, the causal factors of the unprecedented and substantial decline in malaria morbidity and mortality rates in most vulnerable groups in these endemic areas are multifaceted, including not only the spread of malaria and its related effects but also political and financial willingness, commitment and funding by governments and international donors. The benefits of scaling up the impact of malaria coverage interventions, improvement of health system approaches and sustained commitment of stakeholders are highlighted, although considerable efforts are still necessary in Sub-Sahara Africa. Furthermore, novel integrated control strategies aiming at moving malaria from epidemic status to control towards elimination, require solid research priorities both for sustainability of the most efficient existing tools and intervention coverage, and in gaining more insights in the understanding of the epidemiology, pathogenesis, vector dynamics, and socioeconomic aspects of the disease. In conclusion, political commitment and financial investment of stakeholders in sustaining the scaling up impact of malaria control interventions, networking between African and Chinese scientists, and their Western partners are urgently needed in upholding the recent gains, and in translating lessons learnt from the Chinese malaria control achievements and successes into practical interventions in malaria endemic countries in Africa and elsewhere.

【 授权许可】

   
2012 Tambo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Roll Back Malaria: Malaria funding & resource utilization: The first decade of Roll Back Malaria. Progress & Impact Series. Number 1. 2010. Available http://www.rollbackmalaria.org/ProgressImpactSeries/report1.html webcite. accessed on April 24, 2012
• [2]The Global Fund to Fight AIDS, Tuberculosis and Malaria: Malaria Background. www.theglobalfund.org webcite (accessed on 8 April 2012)
• [3]Eisele TP, Larsen DA, Walker N, Cibulskis RE, Yukich JO, Zikusooka CM, Steketee RW: Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001–2010. Malaria J 2012, 11:93. BioMed Central Full Text
• [4]Bruce-Chwatt LJ, Black RH, Candfield CJ, Clyde DF, Peters W, Wernsdorfer WH: Chemotherapy of Malaria. 2nd edition. World Health Organization, Geneva; 1986:260.
• [5]World Health Organization: Malaria eradication in 1960. WHO Chron 1961, 15:201-211.
• [6]UNICEF/World Health Organizatio: Alma Atta Declaration. International Conference on Primary Health Care, Alma-Ata, USSR, 6–12, September 1978
• [7]Breman JG: The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg 2001, 64(1–2 Suppl):1-11.
• [8]Zhou ZJ: The malaria situation in the People's Republic of China. Bull World Health Organ 1981, 59(6):931-6.
• [9]WHO: Insecticide-treated mosquito nets: a WHO position statement. World Health Organization, Global Malaria Programme, Geneva; 2007. http://apps.who.int/malaria docs/itn/ITNspospaperfinal.pdf webcite
• [10]Snow Robert W, Trape J-F, Marsh K: The past, present and future of childhood malaria mortality in Africa. Trends Parasitol 2001, 17:593-597.
• [11]WHO/AFRO: Forty second session WHO Regional Committee for Africa. Progress and prospects for the 1990s Brazzaville, Republic of Congo, 2nd -9th Sept.1992
• [12]WHO/RBM: The Abuja Declaration and the Plan for Action. An extract from the African Summit on Roll Back Malaria. Roll Back Malaria Partnership, World Health Organization, Geneva; 2000. http://www.rbm.who.int/gmap/2-2.html webcite. accessed on April 8, 2012
• [13]WHO Regional Office for Africa: Manual for Developing a National Malaria Strategic Plan. WHO: Regional Office for Africa; 2011.
• [14]Zhou SS, Wang Y, Li Y: Malaria situation in the People’s Republic of China in 2010. Chin J Parasitol and Parasit Dis 2011, 29:401-403.
• [15]Kondrachine AV, Trigg’s PI: Global overview of malaria. Ind J Med Res 1997, 106:39-52.
• [16]Breman JG: Conquering the intolerable burden of malaria: What's new, what's needed: a summary? Am J Trop Med Hyg 2004, 71:1-15.
• [17]Ministry of Health: The malaria situation in the People’s Republic of China. 1990. in Chinese
• [18]Liu X, Cao H: P.R. China's cooperative medical system: Its historical transformations and the trend of development. J Public Health Policy 1992, 13:501-511.
• [19]Greenwood BM: Control to elimination: Implications for malaria research. Trends Parasitol 2008, 24:449-454.
• [20]Steketee Richard W, Campbell Carlos C: Impact of national malaria control scale-up programmes in Africa magnitude and attribution of effects. Malaria J 2010, 9:299. BioMed Central Full Text
• [21]Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM: Shrinking the malaria map: Progress and prospects. Lancet 2010, 5:132.
• [22]Flaxman AD, Fullman N, Otten MW Jr, Menon M, Cibulskis RE, Marie N, Christopher JL M, Lim SS: Rapid scaling up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: a systematic synthesis of supply, distribution, and household survey data. PLoS Med 2010, 7(8):145-151.
• [23]Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC: Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 1993, 167:932-937.
• [24]Jeffrey S, Malaney P: The economic and social burden of malaria. Nature 2002, 415:680-68.
• [25]Bank W: World Development Report 1993: Investing in Health. Oxford University Press, New York; 1993.
• [26]Akachi Y, Atun R: Effect of Investment in Malaria Control on Child Mortality in Sub-Saharan Africa in 2002–2008. PLoS One 2011, 6(6):e21309.
• [27]Tang LH: Progress in malaria control in P.R. China. Chin Med J 2000, 115:69-92.
• [28]Ndugwa Robert P, Heribert R, Olaf M, Momodou J, Ali S, Bocar K, Brian G, Heiko B: Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns. Malaria J 2008, 7:15. BioMed Central Full Text
• [29]Roll Back Malaria Partnership (2000), WHO: Framework for monitoring progress and evaluating outcomes and impact. Geneva; 2000. [http://www.rbm.who.int/ WHO/CDS /RBM/2000.25 webcite. Accessed on April 8, 2012]
• [30]Roll Back Malaria Partnership (2010): Roll Back Malaria Progress and Impact series. 2010, 1-95.
• [31]Roll Back Malaria Partnership: Eliminating Malaria: Learning from the past, Looking Ahead. 2011. [Progress & Impact Series 8]
• [32]Roll Back Malaria Partnership: Global Malaria Action Plan for a malaria world. Geneva; 2008.
• [33]Rowe AK, Steketee RW: Predictions of the impact of malaria control efforts on all-cause child mortality in sub-Saharan Africa. Am J Trop Med Hyg 2007, 77(Supplement 6):48-55.
• [34]Barnes KI, Chanda P, Ab Barnabas G: Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malaria J 2009, 8:Suppl 1S8.
• [35]Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
• [36]WHO: Atlas of Insecticide Resistance in Malaria Vectors of the WHO African Region. WHO, Geneva; 2005.
• [37]Yip W, Wang H, Hsiao W: The impact of Rural Mutual Health Care on health status: Evaluation of a social experiment in rural P.R. China. Harvard Working paper; 2008.
• [38]Gallup J, Sachs J: The economic burden of malaria. Am J Trop Med Hyg 2001, 64(1, 2S):85-96.
• [39]Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C: Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375:1969-1987.
• [40]O'Meara WP, Mangeni JN, Steketee RW, Greenwood B: Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010, 10:545-555.
• [41]Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, Ehmer P, Nchama GN: Marked increase in child survival after four years of intensive malaria control. Am J Trop Med Hyg 2009, 80:882-888.
• [42]Liu J, Yang B, Cheung W, Yang GJ: Modelling Malaria Diffusion Patterns: A Network Perspective. Inf Dis Poverty 2012, 1(1):11.
• [43]Snow RW, Craig MH, Deichmann U, le Sueur D: A preliminary continental risk map for malaria mortality among African children among children aged 0–4 years. Parasitol Today 1999, 3:99-104.
• [44]Smith DL, Hay SI, Noor AM, Snow RW: Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Trends Parasitol 2009, 25:511-516.
• [45]Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN, Ridl FC, Morris N, Seocharan I, Kunene S, La Grange JJ, Mthembu JD, Maartens F, Martin CL, Barreto A: Seven years of regional malaria control collaboration–Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 2007, 76:42-47.
• [46]World Health Organisation: Malaria disease burden in South East Asia Region. http://www.searo.who.int/EN/Section10/Section21/Section340_4018.htm webcite., accessed on April 24, 2012
• [47]Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C: Worldwide Incidence of Malaria in 2009: Estimates, Time Trends, and a Critique of Methods. PLoS Med 2011, 12:e1001142.
• [48]WHO: World Malaria Report. 2011. http://www.who.int/malaria/world_malaria_report, 2011/en/index.html webcite. accessed on April 24, 2012
• [49]Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW: The global distribution and population at risk of malaria: past, present and future. Lancet Infect Dis 2004, 4:327-336.
• [50]Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Wes H, Teun B, Drakeley CJ, Ferguson NM, María-Gloria B, Ghani AC: Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 2010, 7:e1000324.
• [51]Fang H, Shuisen Z, Shaosen Z, Hongwei Z, Weidong L: Meteorological factors–based spatio-temporal mapping and predicting malaria in Central P.R. China. Am J Trop Med Hyg 2011, 85:560-567.
• [52]Zhou SS, Fang H, Wang JJ, Zhang SS, Su YP, Tang LH: Malaria J. Malaria J 2010, 9:337. BioMed Central Full Text
• [53]Okell LC, Lucy Smith P, Jayne W, Kara H, Jo L: From intervention to impact: modelling the potential mortality impact achievable by different long lasting, insecticide-treated net delivery strategies. Malaria J 2012, 11:327. BioMed Central Full Text
• [54]Partnership RBM: Global Strategic Plan: Roll Back Malaria 2005–2015. RBM Partnership Secretariat, Geneva; 2005.
• [55]Korenromp EL, Williams BG, Eleanor G, Christopher D, Snow RW: Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet 2003, 3:349-358.
• [56]WHO: WHO recommended insecticide products for treatment of mosquito nets for malaria vector control. WHO Pesticides Evaluation Scheme (WHOPES). World Health Organization, Geneva; 2009. [http://www.who. int/whopes/Insecticides_ITN_Malaria_ok3.pdf webcite. accessed on April 24, 2012]
• [57]Ceesay SJ, Bojang KA, Nwakanma D, Conway DJ, Koita OA, Doumbia SO, Ndiaye D, Coulibaly TF, Diakité M, Traoré SF, Coulibaly M, Ndiaye JL, Sarr O, Gaye O, Konaté L, Sy N, Faye B, Faye O, Sogoba N, Jawara M, Dao A, Poudiougou B, Diawara S, Okebe J, Sangaré L, Abubakar I, Sissako A, Diarra A, Kéita M, Kandeh B, Long CA, Fairhurst RM, Duraisingh M, Perry R, Muskavitch MA, Valim C, Volkman SK, Wirth DF, Krogstad DJ: Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes. Acta Trop 2012, 121(3):166-174.
• [58]Roll Back Malaria Partnership: Partnership: Malaria funding & resource utilization: the first decade of Roll Back Malaria. 2010. [Progress & Impact Series]
• [59]Snow RW, Trape J-F, Marsh K: The past, present and future of childhood malaria mortality in Africa. Trends Parasitol 2001, 17:593-597.
• [60]MARA: Mapping Malaria Risk in Africa. [www.mara.org.za/home webcite.accessed on April 24, 2012]
• [61]Tour′e YT, Oduola AMJ, Morel CM: The Anopheles gambiae genome: next steps for malaria vector control. Trends Parasitol 2012, 20:142-149.
• [62]WHO: World Malaria Report 2009. WHO, Geneva; 2009. [http://www.who.int/malaria/world_malaria_report _2009/ en/index.html webcite, accessed on 18 February 2012]
• [63]Sachs G: An economic analysis indicates that the burden of malaria is great. In report of the African Summit on Roll Back Malaria, Abuja. World Heath Organization; 2000.
• [64]Nájera JA, González-Silva M, Alonso PL: Some lessons for the future from the global malaria eradication programme (1955–1969). PLoS Med 2011, 8:e1000412.
• [65]WHO: Targets for Malaria Control. World Health Organization, Geneva; 2010.
• [66]Noor AM, Mutheu JJ, Tatem AJ, Hay SI, Snow RW: Insecticide-treated net coverage in Africa:mapping progress in 2000–07. Lancet 2009, 373:58-67.
• [67]Ministry of Health: Malaria Surveillance Project in P.R. China. Beijing; 2005. in Chinese
• [68]Steketee RW, Eisele TP: Is the scale up of malaria intervention coverage also achieving equity? PLoS One 2009, 4(12):e8409.
• [69]MEASURE DHS: Demographic and Health Surveys. [http://www.measuredhs.com webcite accessed on 4, March 2012]
• [70]UNICEF, RBM Partnership, The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM): Malaria and children: Progress in intervention coverage. UNICEF, New York; 2009.
• [71]Zhou SS, Wang Y, Fang W, Tang LH: Malaria situation in the People’s Republic of China in 2009. Chin J Parasitol Parasit Dis 2011, 27:1-3. in Chinese
• [72]Yan Z, Qiyong L, Rongsheng L, Xiaobo L, Guangchao Z, Jingyi J, Hongsheng L, Zhifang L: Spatial-temporal analysis of malaria and the effect of environmental factors on its incidence in Yongcheng, P.R. China, 2006–2010. BMC Public Health 2012, 12:544. BioMed Central Full Text
• [73]Djimde A, Ogbobara K, Doumbo MD, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su X, Nomura T, Fidock DA, Wellems T, Christopher P: A molecular marker for chloroquine resistant falciparum malaria. New Eng J Med 2001, 344:257-263.
• [74]Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM: Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments. Am J Trop Med Hyg 2011, 84:936-943.
• [75]The maIERA Consultative Group on Drugs: A research agenda for malaria eradication: drugs. PLoS Med 2011, 8:e1000402.
• [76]Sibley CH, Barnes KI, Watkins WM, Plowe CV: A network to monitor antimalarial drug resistance: a plan for moving forward. Trends Parasitol 2008, 24(1):43-48.
• [77]Lourens C, Watkins WM, Barnes KI, Sibley CH, Guerin PJ, White NJ, Lindegardh N: Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malaria J 2010, 9:375. BioMed Central Full Text
• [78]INDEPTH Network Demographic Surveillance System sites. 2002. [http://www.indepth-network.org/dss_ site_ profiles/ dss_africa webcite. accessed on 18 February 2012]
• [79]Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, Jima D, Gausi K, Komatsu R, Korenromp E, Low-Beer D, Grabowsky M: Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malaria J 2009, 8:14. BioMed Central Full Text
• [80]Webster J, Kweku M, Dedzo M, Tinkorang K, Bruce J, Lines J, Chandramohan D, Hanson K: Evaluating delivery systems: complex evaluations and plausibility inference. Am J Trop Med Hyg 2010, 82:672-677.
• [81]The Global Fund to fight AIDS, Tuberculosis and Malaria: Affordable Medicines Facility-malaria (AMFm). 2010. [http://www.theglobalfund. org/en/amfm webcite.accessed on 4 March 2012]
• [82]Lengeler C, Sharp B: Technical Report: Reducing Malaria's Burden: evidence of effectiveness for decision makers. 2003. [http;//www.globalhealth.org/assets/publications /malaria.pdf http://www.global health. org / assets /publications /malaria.pdf webcite. accessed on April 28, 2011]
• [83]ter Kuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kolczak MS, Kariuki SK, Shi YP, Kwena AM, Vulule JM, Nahlen BL: Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey. Am J Trop Med Hyg 2003, 68:100-107.
• [84]Plowe C: Monitoring antimalarial drug resistance: making the most of the tools at hand. J Exp Biol 2003, 206:3745-3752.
• [85]Snow RW, Amratia P, Kabaria CW, Noor AM, Marsh K: The Changing Limits and Incidence of Malaria in Africa: 1939–2009. Adv Parasitol 2012, 78:435-446.
• [86]Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC: Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 2008, 5:e226.
• [87]Chen JH, Wang H, Xia-Xu Chen JX, Bergquist R, Tanner M, Utzinger JU, Zhou XN: Frontiers of parasitology research in the People's Republic of China: infection, diagnosis, protection and surveillance. Parasit Vectors 2012, 5:221. BioMed Central Full Text
• [88]Sinka ME, Bangs MJ, Sylvie M, Theeraphap C, Patil AP, Temperley WH, Gething PW, Iqbal RFE, Kabaria CW, Harbach RE, Hay SI: The dominant Anopheles vectors of human malaria in the Asia-Pacific region: occurrence data, distribution maps and bionomic précis. Parasit Vectors 2011, 4:89. BioMed Central Full Text
• [89]Sinka ME, Bangs MJ, Sylvie M, Maureen C, Mbogo CM, Janet H, Patil AP, Temperley WH, Gething PW, Kabaria CW, Okara RM, Van Thomas B, Godfray HCJ, Harbach RE, Hay SI: The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic précis. Parasit Vectors 2010, 3:117. BioMed Central Full Text